Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo - Wikidata - thesis-toulmin - TriplyDB

Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo

Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo

http://www.wikidata.org/entity/Q33410205

about

Non-invasive vulnerable plaque imaging: how do we know that treatment works?Role of P38 MAPK on MMP Activity in Photothrombotic Stroke Mice as Measured using an Ultrafast MMP Activatable Probe.Molecular imaging of inflammation in atherosclerosis.Imaging evaluation of inflammation in the musculoskeletal system: current concepts and perspectives.Targeted probes for cardiovascular MRI In vivo optical molecular imaging of matrix metalloproteinase activity in abdominal aortic aneurysms correlates with treatment effects on growth rate Imaging biomarkers of cardiovascular disease.Matrix metalloproteinase activation predicts amelioration of remodeling after dietary modification in injured arteries.Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases Heteroditopic binding of magnetic resonance contrast agents for increased relaxivity.Atherosclerosis plaque heterogeneity and response to therapy detected by in vivo molecular imaging of matrix metalloproteinase activation.Design of nanovectors for therapy and imaging of cardiovascular diseases Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer.Stroke-related translational research.Imaging of the unstable plaque: how far have we got?Emergence of molecular imaging of aortic aneurysm: implications for risk stratification and management.Molecular imaging to identify the vulnerable plaque--from basic research to clinical practice.Evaluating efficacy of pharmaceutical interventions in atherosclerosis: role of magnetic resonance imaging and positron emission tomography.Molecular MRI of the Cardiovascular System in the Post-NSF Era Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.Visualizing the atherosclerotic plaque: a chemical perspective.Effect of Peptide-Chelate Architecture on Metabolic Stability of Peptide-based MRI Contrast Agents.Molecular MRI of atherosclerotic plaque progression in an ApoE(-/-) mouse model with a CLT1 peptide targeted macrocyclic Gd(III) chelate.Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors.MR molecular imaging of prostate cancer with a small molecular CLT1 peptide targeted contrast agent.A Microscopic and Biomarker Evaluation of Embolic Filter Debris Collected During Carotid Artery Stenting.The year in molecular imaging.Molecular imaging of experimental abdominal aortic aneurysms.MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosis From lipodystrophy to cardiovascular disease: new insight into the management of HIV infection

P2860

Q27020959-7C91D6E4-0142-48E1-967D-A9156905AF0E Q27305326-C7949898-FD10-434F-A9DC-F1AA7F2ABE36 Q30446268-F52933DE-48EA-4DBE-969A-514736151C08 Q30628109-D0820BCD-0DBD-40FC-9237-0B702D7F4696 Q33901726-7859CA4E-1ABC-4041-AC86-E60ED5F801F7 Q34103996-0E3D1CF6-C26A-469E-A04A-5E1CFDA81D9E Q34109961-03C64DE8-EE52-48D4-ADBE-97CD432831D5 Q34420376-00286CA5-BDA3-48FB-86D2-D80E773A19A1 Q35042615-B9D28898-0A75-492E-B2E1-606592714484 Q35249665-541B6177-DFBB-434C-BBF3-46E9A3C501B5 Q35607634-E77276C6-35BE-4E1A-87B4-6BAEBA28B888 Q36119295-5B9F2E56-8182-440B-B672-556711040009 Q36141999-07C5DD0A-F8C1-433C-8FAF-D6516ACB97DE Q36555396-DD2DDB9A-47FB-4DFA-8F5B-D54F515E6888 Q36953709-406A22B9-EA74-484E-B8D1-C3BD2CBF5F24 Q37407240-C69E1B22-0ED6-4762-BB0C-D3831F93DA98 Q37709428-85BF51B0-8ECA-41C0-B5A5-3940FE148234 Q38043973-86FF6955-5C2F-4201-A7B7-2179D882988A Q38067325-46BA8ED6-9AD5-46ED-8B25-4E1FE827824A Q38090583-263643A0-6536-4774-81DC-CA43BC36FFE4 Q38094125-67196DC5-FFD0-4348-B4BF-B359A587CC34 Q38187881-3AD4D98A-0989-49A9-A9AF-E784CA196048 Q40887045-9A3ED686-CA0A-4440-A6AD-AA83D6C92107 Q41847179-968B515E-EA6A-449F-B9C6-D9D3320EC799 Q42256348-D4C90E5D-3EB2-4CA9-BF9F-03048BD97653 Q42829048-AC54C273-C180-4D9F-99FF-75EC649DF879 Q51537387-3F83FF14-6904-430B-8116-21F8A3EE9CA9 Q53289963-F038D478-9452-4B64-9B56-AEA7D4B54A4F Q55099835-B87BA53A-917E-4B1A-9A93-79BBC82CB707 Q57185167-FF71EC46-8C55-46C1-BD20-6DC79461FE1B Q58798012-69EA90B2-FEE5-40B2-BA5C-A023667EC9C3

P2860

Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo

http://www.wikidata.org/entity/Q33410205

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo

@ast

Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo

@en

type

label

Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo

@ast

Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo

@en

prefLabel

Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo

@ast

Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo

@en

P1433

Q33410205-6D66299C-8D8B-4D09-A171-3E563F93C593

P1476

Q33410205-CE8AD056-8A1D-4165-93C9-045FBAC020DE

P2093

Q33410205-05C41250-C09E-482E-90D0-47A228E48FDA

Q33410205-0A33724D-CF39-4C7B-ACFA-2C3FB167FA5B

Q33410205-2B53CAB7-E1B2-4309-9ABE-C012DD91B189

Q33410205-377DCD7C-4F7A-4FC9-BCD4-8890052909F7

Q33410205-509A7849-36F2-43FD-8010-C3E0A037971E

Q33410205-7754E6EB-BB43-46D0-8525-BC2E09B82148

Q33410205-7DB490B6-0CAC-4B76-ABE1-F7BE14965198

Q33410205-AAA15307-C074-49C4-9E1D-DF6829624581

Q33410205-D312F48E-E61A-4394-9139-A05DB01555EE

Q33410205-E4FDA3DD-344C-4403-91EE-FE04DE1D8D58

P2860

Q33410205-06351935-4BB6-4EC7-8967-D50E41A103A0

Q33410205-0722CBDE-B780-4884-9DE4-6B3A67B1A452

Q33410205-10350ACB-7F0A-487C-9247-4DA18CF4A924

Q33410205-1E8F80C7-3A2E-4508-BF56-D82135F92E73

Q33410205-22436268-6489-48A0-8011-1DAD269B5E50

Q33410205-2F94A576-EA81-4D9F-875F-60844DC4B390

Q33410205-4ABEB4A2-E61E-4954-A887-5599E2F02779

Q33410205-6A33B3C1-8F4B-4730-9D79-7ACA65BF5806

Q33410205-800703F2-A01E-4C44-A074-CFBEFCA04A54

Q33410205-81CEEB34-700D-4E97-B6A6-2F2840362B23

P304

Q33410205-4C617749-78E5-4177-837B-EB83003265F8

P31

Q33410205-09A62F7B-E646-4494-AC0A-A693EC6D1102

P356

Q33410205-E4D4F852-9A72-45DA-9F9A-A01202DF4B82

P407

Q33410205-77E43D91-AE70-4073-B454-E1E1A6BEF0C5

P433

Q33410205-E8747449-91BB-4D9D-89E5-F322FB264389

P478

Q33410205-63AA1E57-F3EA-4B0D-9BB1-419015E8179D

P50

Q33410205-41405E42-CBF1-4B82-A74E-9F498A392E73

Q33410205-DF8BC991-F2D2-4029-9946-E8CE4D743C82

P577

Q33410205-7D6ECCD0-D7C3-4B47-AF8A-DEA94D10E203

P5875

Q33410205-04FD5985-9889-4C1E-A7A5-90FFB72D0B2A

P698

Q33410205-0C03D532-EA59-405A-80EA-A2BF61E5F1A0

P921

Q33410205-9F49C6C3-D048-4061-9803-191A98A983E5

P932

Q33410205-542FAA35-DAAA-4B2B-829F-2B5FC256EA62

P356

RADIOL.2511080539

P1433

P1476

Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo

@en

P2093

Claire Corot

http://www.w3.org/2001/XMLSchema#string

David B Weinreb

http://www.w3.org/2001/XMLSchema#string

Eric Lancelot

http://www.w3.org/2001/XMLSchema#string

Esad Vucic

http://www.w3.org/2001/XMLSchema#string

Juan Gilberto S Aguinaldo

http://www.w3.org/2001/XMLSchema#string

Marc Sirol

http://www.w3.org/2001/XMLSchema#string

Smbat Amirbekian

http://www.w3.org/2001/XMLSchema#string

Soizic Le Greneur

http://www.w3.org/2001/XMLSchema#string

Vardan Amirbekian

http://www.w3.org/2001/XMLSchema#string

Zahi A Fayad

http://www.w3.org/2001/XMLSchema#string

P2860

Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle.

Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI.

Clinical imaging of the high-risk or vulnerable atherosclerotic plaque.

Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries.

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases.

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

Atherothrombosis and high-risk plaque: part I: evolving concepts.

P304

429-438

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.2511080539

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

251

http://www.w3.org/2001/XMLSchema#string

P50

Edward A Fisher

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24022857

http://www.w3.org/2001/XMLSchema#string

P698

19224894

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

2674553

http://www.w3.org/2001/XMLSchema#string